Drawing for LIXA

USPTO serial 98792313

LIXA

Reviewed by CopyMark Law Group

Status 730Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
OH, WON TEAK
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 730: Status 730 means you filed the first six-month extension to delay filing a Statement of Use after a Notice of Allowance. You must file a Statement of Use or another extension before the new deadline.

Need help with LIXA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,246*

Plus Government fees of $600

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michelle Bolos

Michelle Bolos Marshall, Gerstein & Borun LLP233 South Wacker Drive, Suite 6300Chicago, IL 60606United States

Goods and services

ClassDescriptionStatusFirst use
001Surfactants for use in connection with agricultural pesticides; extracellular matrix and extracellular polymeric substances namely polysaccharides, monosaccharides, exopolysaccharides, and proteins for use in the manufacture of agricultural pesticides, animal feed, veterinary products, cleaning agents and surface hygiene productsACTIVE—
003Cosmetics; cleaning agents for medical purposes, cleaning agents for hygiene purposes, cleaning agents for veterinary purposes, antimicrobial cleaning agentsACTIVE—
005Pharmaceutical products to maintain or enhance health or treat disease, namely infectious disease, autoimmune disease, inflammatory disease and other immune disorders ; veterinary products, namely pharmaceuticals, nutritional supplements, complementary health products, anti-infectives and anti-inflammatories; antibiotics; pharmaceutical products to prevent or treat infectious disease, autoimmune disease, inflammatory disease and other immune disorders; veterinary vaccines for livestock and companion animals for treating infectious disease, autoimmune disease, inflammatory disease and other immune disorders; antibiotic adjuvants; Pharmaceutical products, ingredients and preparations, namely, pharmaceutical preparations for the impairment and prevention of infection, namely planktonic and microbial biofilm colonies, the reversal of microbial resistance, the potentiation of antimicrobial agents, endotoxicity protection, anti-inflammatory and immune system enhancement; products which enhance the health of microbiomes, namely dietary supplements, gut health supportive treatments and products, functional foods; antimicrobial biocide, antibiotic, bactericidal agents, bacteriostatic agents for use in pharmaceuticals, medical materials such as wound dressings, sanitary preparations and animal health products; resistance breakers, namely, pharmaceuticals, medical materials, sanitary preparations and veterinary products; human and animal antimicrobial treatments, namely, antibiotics and pharmaceuticals to be administered alongside, or instead of, antibiotics; pharmaceutical preparations to prevent or mitigate bacterial biofilms and infections; disinfectants for medical purposes, disinfectants for hygiene purposes, disinfectants for veterinary purposes, antimicrobial disinfectantsACTIVE—
031Animal feedACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 28, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 27, 2026EX1GSOU EXTENSION 1 GRANTED—
Jul 27, 2026EXT1SOU EXTENSION 1 FILED—
Jul 27, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 27, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 2, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 2, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 26, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 5, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 17, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 17, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 17, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 16, 2025XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Jul 16, 2025XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Apr 17, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 17, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 17, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 12, 2025DOCKASSIGNED TO EXAMINER—
Apr 11, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 2, 2024AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Dec 2, 2024ALIEASSIGNED TO LIE—
Oct 10, 2024PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Oct 9, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance